Breast and Cervical Cancer Screening

Cancer among ladies is a noteworthy general medical issue in the United States. Around 40% of American ladies are determined to have a nondermatological growth amid their lifetime, and breast tumor is second just to lung disease as a reason for malignancy related mortality among women. Cervical disease is the tenth most regular tumor among ladies and records for right around 2% of female malignancy passing. The American Cancer Society predicts that around 40 200 ladies will have kicked the bucket from breast growth and 4400 will have passed on from cervical disease in the year 2001.

Mammography and Papanicolaou (Pap) tests are fundamental parts of early discovery and treatment, and death rates are significantly diminished when bosom and cervical tumors are identified and treated at a beginning time.

  • Antiestrogen Binding Sites
  • Effects of Antiestrogens on cell Cycle Progression
  • Development of Tamoxifen for Breast Cancer Therapy
  • HER2 targeted drugs
  • Radiation Therapy
  • Adjuvant Systemic Therapy of Breast Cancer

Related Conference of Breast and Cervical Cancer Screening

Breast and Cervical Cancer Screening Conference Speakers